The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein

European Journal of Neuroscience

Volumn 12, Issue 3, 2000, Pages 1123-1127

  Porcella, Anna ^a   Maxia, Chiara ^b   Gessa, Gian Luigi ^c   Pani, Luca ^c,d  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Neuroscienze PharmaNess Scarl   (Italy)

^c San Michele Hospital   (Italy)

^d CNR   (Italy)

Author keywords

Gene expression; Glaucoma; Marijuana

Indexed keywords

ANTIBODY; ANTIGLAUCOMA AGENT; BETA 2 MICROGLOBULIN; CANNABINOID RECEPTOR; CANNABIS; GLYCOSYLATED PROTEIN; MESSENGER RNA;

AMINO TERMINAL SEQUENCE; ARTICLE; CENTRAL NERVOUS SYSTEM; CILIARY BODY; CONTROLLED STUDY; EYE; GLAUCOMA; HUMAN; HUMAN TISSUE; INTRAOCULAR PRESSURE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; WESTERN BLOTTING;

BLOTTING, WESTERN; DNA; EYE; EYE PROTEINS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOBLOTTING; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 0034025978     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.01027.x     Document Type: Article

References (34)

1. Ameri, A. (1999) The effects of cannabinoids on the brain. Prog. Neurobiol., 58, 315-348.
2. Buckley, N.E., Hansson, S., Harta, G. & Mezey, E. (1998) Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat. Neuroscience., 82, 1131-1149.
3. Colasanti, B.K.J. (1990) A comparison of the ocular and central effects of delta 9-tetrahydrocannabinol and cannabigerol. Ocul. Pharmacol., 6, 259-269.
4. Declaration of Helsinki (1984) Adopted in 1964 by the 18th World Medical Assembly in Helsinki, Finland, and revised by the 29th World Medical Assembly in Tokyo in 1975. In Varga, A.C. (ed.), The Main Issue in Bioethics Revised Edition. Paulist Press, New York.
5. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A. & Mechoulam, R. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258, 1946-1949.
6. Dove Pettit, D.A., Harrison, M.P., Olson, J.M., Spencer, R.F. & Cabrai, G.A. (1998) Immunohistochemical localization of the neural cannabinoid receptor in the rat brain. J. Neurosci. Res., 51, 391-402.
7. Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. & Casellas, P. (1995) Expression of central and peripheral cannabinoid receptor in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 232, 54-61.
8. Gerard, C., Mollereau, C., Vassart, G. & Parmentier, M. (1990) Nucleotide sequence of a human cannabinoid receptor cDNA. Nucl. Acids Res., 18, 7142-7148.
9. Hepler, R.S. & Franck, I.R. (1971) Marihuana smoking and intraocular pressure. JAMA, 217, 173-180.
10. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., De Costa, B.R. & Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in the rat brain: a quantitative in vitro autoradiographic study. J. Neurosci., 11, 563-583.
11. Hodges, L.C., Reggio, P.H. & Green, K. (1997) Evidence against cannabinoid receptor involvement in intraocular pressure effects of cannabinoids in rabbits. Ophthalmic Res., 29, 1-5.
12. 1 cannabinoid receptors using receptor peptide fragments and site-directed antibodies. Mol. Pharmacol, 53, 504-510.
13. Kaufmann, P.L. (1998) Marijuana and glaucoma. Arch. Ophathalmol., 116, 1512-1513.
14. Martin, B.R. (1986) Cellular effects of cannabinoids. Pharmacol. Rev., 38, 45-47.
15. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
16. Matsuda, S., Kanemitsu, N., Nakamura, A., Mimura, Y., Ueda, N., Kurahashi, Y. & Yamamoto, S. (1997) Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissue. Exp. Eye Res., 64, 707-711.
17. Merrit, J.C. (1982) Glaucoma, hypertension, and marijuana. J. Natl Med. Assoc., 74, 715-716.
18. Nahas, G.G. (1984) The medical use of cannabis. In Nahas, G.G., (ed.) Marijuana in Science and Medicine. Raven Press, New York, pp. 247-261.
19. Onanivi, E., Chakrabarti, A. & Chaudhuri, G. (1996) Cannabinoid receptors genes. Prog. Neurobiol, 48, 275-305.
20. Pate, D.W., Järvinen, K., Urtti, A., Jarho, D., Fich, M., Mahadevan, V. & Järvinen, T. (1996) Effects of topical anandamides on intraocular pressure in normotensive rabbits. Life Sci., 21, 1849-1860.
21. Perez-Reyes, M., Wagner, D., Wall, M.E. & Davis, K.H. (1976) Intravenous administration of cannabinoids on intraocular pressure. In Braude, M.C., Szara, S., (eds), The Pharmacology of Marihuana Raven Press., New York, pp. 815-824.
22. Porcella, A., Casellas, P., Cessa, G.L. & Pani, L. (1998a) Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the anliglaucoma properties of marihuana. Mol. Brain Res., 58, 240-245.
23. 9-tetrahydrocannabinol increases sequence-specific AP1 DNA-binding activity and Fos-related antigens in the rat brain. Eur. J. Neurosci., 10, 1743-1751.
24. Randall, D.M. & Kendall, D.A. (1998) Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol. Sci., 19, 55-58.
25. Schlicker, E., Timm, J., Zentner, J. & Gothert, M. (1997) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch. Pharmacol., 356, 583-589.
26. Schlicker, E., Timm, J. & Göthert, M. (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch. Pharmacol, 354, 791-795.
27. Shire, D., Carillon, C., Kagdad, M., Calandra, B., Rinaldi-Carmona, M., Le Fur, G., Caput, D. & Ferrara, P. (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biochem., 270, 3726-3731.
28. Song, C. & Howlett, A. (1995) Rat brain cannabinoid receptors are N-linked glycosilated proteins. Life Sci., 56, 1983-1989.
29. Straiker, A., Stella, N., Piomelli, D., Mackie, K., Karten, H.J. & Macguire, G. (1999) Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc. Natl Acad. Sci. USA, 96, 14565-14570.
30. Sugrue, M.F. (1997) New approaches to antiglaucoma therapy. J. Med. Chem., 40, 2793-2809.
31. Tsou, K., Brown, S., Sañudo-Peña, M.C., Mackie, K. & Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
32. Twitchell, W., Brown, S. & Mackie, K. (1997) Cannabinoids inhibit N and P/ Q-type calcium currents in cultured rat hippocampal neurons. J. Neurophysiol, 78, 43-50.
33. Wagner, J.A., Varga, K., Ellis, E.F., Rzigalinski, B.A., Martin, B.R. & Kunos, G. (1997) Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock. Nature., 390, 518-521.
34. Wallace, L.M. & Alward, M.D. (1998) Medical management of glaucoma. New England J. Med., 339, 1298-1307.